CDK4 and head and neck squamous cell carcinoma: LY2835219 successfully prevented cell cycling into S phase, whereas metformin inhibited mTOR and STAT3 pathways that are normally upregulated in the SASP by senescent HNSCC cells following CDK4/6 inhibition [89].